These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft. Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864 [TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial. Kasetsuwan N; Reinprayoon U; Satitpitakul V Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Mutlu FM; Sobaci G; Tatar T; Yildirim E Ophthalmology; 1999 Apr; 106(4):817-21. PubMed ID: 10201608 [TBL] [Abstract][Full Text] [Related]
9. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Mauro J; Foster CS Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347 [TBL] [Abstract][Full Text] [Related]
10. Effect of subconjunctival bevacizumab on primary pterygium. Teng CC; Patel NN; Jacobson L Cornea; 2009 May; 28(4):468-70. PubMed ID: 19411971 [TBL] [Abstract][Full Text] [Related]
11. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial. Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions. Ozer A; Yildirim N; Erol N; Yurdakul S Ophthalmologica; 2009; 223(4):269-73. PubMed ID: 19339811 [TBL] [Abstract][Full Text] [Related]
14. Subconjunctival bevacizumab injection in treatment of pterygium. Besharati MR; Manaviat MR; Souzani A Acta Med Iran; 2011; 49(3):179-83. PubMed ID: 21681707 [TBL] [Abstract][Full Text] [Related]
15. Bevacizumab and ocular wound healing after primary pterygium excision. Banifatemi M; Razeghinejad MR; Hosseini H; Gholampour A J Ocul Pharmacol Ther; 2011 Feb; 27(1):17-21. PubMed ID: 20977367 [TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery. Hwang S; Choi S Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453 [TBL] [Abstract][Full Text] [Related]
17. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Sharma A; Gupta A; Ram J; Gupta A Ophthalmic Surg Lasers; 2000; 31(4):301-7. PubMed ID: 10928667 [TBL] [Abstract][Full Text] [Related]
18. A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection. Oh DH; Chun YS; Kim JC Korean J Ophthalmol; 2011 Feb; 25(1):57-9. PubMed ID: 21350697 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results. Enkvetchakul O; Thanathanee O; Rangsin R; Lekhanont K; Suwan-Apichon O Cornea; 2011 Nov; 30(11):1213-8. PubMed ID: 21915047 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. Motarjemizadeh Q; Aidenloo NS; Sepehri S Int Ophthalmol; 2016 Feb; 36(1):63-71. PubMed ID: 25943172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]